PTC Therapeutics, Inc.
PTCT
$47.39
$0.982.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.15B | 1.02B | 1.09B | 890.90M | 882.81M |
| Total Receivables | 158.55M | 199.98M | 187.15M | 211.18M | 261.02M |
| Inventory | 23.19M | 35.67M | 31.83M | 30.06M | 30.58M |
| Prepaid Expenses | 22.93M | 22.52M | 45.64M | 36.61M | 41.62M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.40M | -- | -- | -- | 2.60M |
| Total Current Assets | 1.37B | 1.28B | 1.36B | 1.17B | 1.22B |
|
|
|||||
| Total Current Assets | 1.37B | 1.28B | 1.36B | 1.17B | 1.22B |
| Net Property, Plant & Equipment | 117.66M | 122.64M | 123.12M | 183.97M | 178.99M |
| Long-term Investments | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Goodwill | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Total Other Intangibles | 118.79M | 330.37M | 329.88M | 330.04M | 379.50M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.70M | 25.34M | 23.10M | 24.55M | 36.25M |
| Total Assets | 1.71B | 1.84B | 1.92B | 1.79B | 1.90B |
|
|
|||||
| Total Accounts Payable | 17.27M | 13.29M | 24.28M | 27.46M | 6.05M |
| Total Accrued Expenses | 261.62M | 301.66M | 260.63M | 286.56M | 366.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 271.18M | 274.37M | 271.00M | 243.62M | 210.32M |
| Total Finance Division Other Current Liabilities | 30.90M | 21.40M | 53.89M | 16.91M | 20.48M |
| Total Other Current Liabilities | 30.90M | 21.40M | 53.89M | 16.91M | 20.48M |
| Total Current Liabilities | 580.98M | 610.71M | 609.80M | 574.55M | 603.10M |
|
|
|||||
| Total Current Liabilities | 580.98M | 610.71M | 609.80M | 574.55M | 603.10M |
| Long-Term Debt | 2.11B | 2.11B | 2.11B | 1.90B | 1.90B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 90.52M | 98.34M | 94.69M | 120.41M | 114.81M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 22.23M | 77.99M | 77.35M | 92.25M | 92.35M |
| Total Liabilities | 2.80B | 2.90B | 2.90B | 2.68B | 2.71B |
|
|
|||||
| Common Stock & APIC | 2.57B | 2.53B | 2.51B | 2.49B | 2.47B |
| Retained Earnings | -3.65B | -3.58B | -3.47B | -3.38B | -3.28B |
| Treasury Stock & Other | -25.89M | -4.34M | -16.50M | -5.56M | -1.29M |
| Total Common Equity | -1.10B | -1.05B | -980.18M | -893.92M | -818.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.10B | -1.05B | -980.18M | -893.92M | -818.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.10B | -1.05B | -980.18M | -893.92M | -818.56M |
|
|
|||||